GlassScriptPhysician profile
Amanda K Worthington
NPI 1700480340
$988.25
in general payments reported to CMS, 2019-2025
9 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $249 · 2022: $178 · 2023: $127 · 2024: $225 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $283.62 | 2021-2024 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $206.51 | 2021-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $184.07 | 2021-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $120.57 | 2021-2025 | Trelegy Ellipta |
| Abbvie INC. | $91.57 | 2021-2025 | |
| Corcept Therapeutics | $60.62 | 2022-2023 | Korlym |
| Scpharmaceuticals INC. | $23.96 | 2025 | |
| Sunovion Pharmaceuticals INC. | $14.53 | 2022 | |
| Genentech USA, INC. | $2.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Worthington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.